All articles tagged with #weight loss jabs
The family of Alice Webb, who died after a cosmetic procedure, is angry that Jordan Parke, known as the 'Lip King', is still illegally selling prescription-only weight-loss jabs online, despite his arrest and ongoing investigations, highlighting concerns over unregulated cosmetic practices and the need for stricter industry oversight.
A study has been launched to investigate serious side effects, including pancreatitis, linked to weight loss drugs like Mounjaro, Ozempic, and Wegovy, after reports of hospitalizations and deaths. The research aims to identify genetic risk factors to improve safety and reduce adverse reactions, with data collection through the MHRA's Yellow Card scheme and saliva samples from affected patients.
A study suggests that weight loss medications like Wegovy and Mounjaro may be less effective in real-world settings compared to clinical trials, with bariatric surgery resulting in significantly greater weight loss. Factors such as cost, access, and adherence may influence the effectiveness of these drugs outside of controlled environments.
Women using weight-loss injections like Wegovy and Mounjaro are advised to stop if trying for a baby, pregnant, or breastfeeding due to unknown risks to the fetus. Experts highlight concerns over safe use, especially as many women acquire these drugs without proper medical guidance, risking unintended pregnancies and potential harm. The UK regulator recommends contraception during and after treatment, but access issues complicate safe practices.
A study suggests that weight loss jabs like Wegovy, originally designed for obesity and diabetes, could be a more cost-effective and efficient treatment for drug addiction than traditional rehab. The study found that opiate addicts given a similar drug reported 40% fewer cravings, with some experiencing periods free of cravings entirely. The drug, liraglutide, costs significantly less than high-end rehab clinics and is being considered as a potential treatment for opioid addiction, with potential uses for smoking cessation as well.
Doctors are urging slim individuals in the UK not to use weight loss jabs, such as semaglutide, unless they genuinely need them for health reasons. The demand for these drugs, driven by celebrity endorsements, is threatening the supply for type 2 diabetics who require them. Prescription guidelines need to be stricter to prevent inappropriate usage. Semaglutide, which tricks the brain into feeling full, has been hailed as a breakthrough in the fight against obesity. However, experts warn that the drugs should be taken long-term, as studies show that weight can be rapidly regained once the jabs are stopped. Side effects and supply issues further complicate the situation.
Europe's drugs regulator, the European Medicines Agency (EMA), is conducting a review of weight-loss jabs, including Wegovy, Saxenda, and similar drugs, after being alerted to a possible link to thoughts of suicide and self-harm among users. The review was prompted by three cases reported in Iceland. The EMA's Pharmacovigilance Risk Assessment Committee (PRAC) will assess the risks of using weight-loss medication containing semaglutide or liraglutide. Suicidal thoughts are already listed as a possible side effect in product leaflets, but suicidal behavior is not currently listed. The EMA will communicate further findings as the review progresses.
The upcoming coronation of Camilla as Queen is a revolutionary move by King Charles, who has fought to ensure the woman he loves is acknowledged as his rightful queen. However, there are still doubts about Camilla's popularity among the public. Meanwhile, weight-loss jabs are being criticized by some who believe that being overweight is a moral and mental deficiency. Lastly, the use of voter ID in the upcoming local elections is being opposed by Labour, despite the prevalence of photo ID requirements in other areas of life.